CINECA IRIS Institutional Research Information System

CONTI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.758
EU - Europa 3.194
AS - Asia 2.242
SA - Sud America 62
AF - Africa 51
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.651
CN - Cina 1.186
IT - Italia 1.092
SE - Svezia 370
SG - Singapore 360
IE - Irlanda 307
DE - Germania 263
FR - Francia 225
UA - Ucraina 141
FI - Finlandia 135
DK - Danimarca 133
KR - Corea 133
GB - Regno Unito 109
AT - Austria 101
JP - Giappone 101
PL - Polonia 91
VN - Vietnam 86
IN - India 72
ID - Indonesia 66
CA - Canada 56
BE - Belgio 48
HK - Hong Kong 48
TR - Turchia 47
IR - Iran 41
MX - Messico 41
SN - Senegal 38
AU - Australia 34
TW - Taiwan 29
BR - Brasile 27
ES - Italia 25
RU - Federazione Russa 22
GR - Grecia 21
NL - Olanda 21
PT - Portogallo 19
CZ - Repubblica Ceca 14
CL - Cile 12
CH - Svizzera 11
HU - Ungheria 11
TH - Thailandia 10
MY - Malesia 9
PK - Pakistan 9
CU - Cuba 8
EC - Ecuador 8
NO - Norvegia 8
RO - Romania 7
CO - Colombia 6
IL - Israele 6
MO - Macao, regione amministrativa speciale della Cina 6
PE - Perù 6
EG - Egitto 5
LT - Lituania 5
SA - Arabia Saudita 5
BG - Bulgaria 4
EU - Europa 4
BD - Bangladesh 3
CY - Cipro 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
UZ - Uzbekistan 3
AR - Argentina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BT - Bhutan 1
ET - Etiopia 1
GE - Georgia 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TN - Tunisia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 10.348
Salva come PNG Salva come JPEG
Città #
Chandler 611
Fairfield 371
Beijing 336
Torino 332
Dublin 306
Singapore 286
Houston 255
Ashburn 231
Ann Arbor 196
Wilmington 185
Turin 178
Cambridge 167
Woodbridge 163
Seattle 125
Santa Clara 119
Nyköping 115
Dearborn 106
Vienna 96
Villeurbanne 92
Jacksonville 89
Princeton 86
Columbus 85
Medford 84
Redwood City 80
Shanghai 80
Pisa 77
Warsaw 75
Guangzhou 66
Milan 59
Jakarta 55
Nanjing 54
Hangzhou 49
Dong Ket 41
Boston 35
Chengdu 32
Fremont 29
Brussels 28
New York 28
Washington 28
Wuhan 27
Xian 25
Changsha 24
Boardman 23
Helsinki 23
Ottawa 23
Seoul 23
Taipei 23
Zhengzhou 23
Rome 21
San Diego 20
Tokyo 19
Padova 18
Shenyang 18
Chongqing 17
Hong Kong 17
Istanbul 17
Jinan 17
Munich 17
Hyderabad 16
Silver Spring 16
Tianjin 15
Chennai 14
Phoenix 14
Hefei 13
Los Angeles 13
Düsseldorf 11
Falls Church 11
Hebei 11
Norwalk 11
Ankara 10
Athens 10
Kharkiv 10
Kunming 10
Villa Bartolomea 10
Chicago 9
Duncan 9
Parma 9
Toronto 9
Verona 9
Delhi 8
Ecatepec 8
Frankfurt am Main 8
Harbin 8
La Habana 8
London 8
Melbourne 8
Sydney 8
Upper Marlboro 8
Vigliano Biellese 8
Central District 7
Changchun 7
Moscow 7
Paris 7
San Mateo 7
São Paulo 7
Trieste 7
Amsterdam 6
Buffalo 6
Central 6
Cisternino 6
Totale 6.218
Salva come PNG Salva come JPEG
Nome #
Breast cancer stem cell antigens as targets for immunotherapy 949
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 440
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 400
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 361
NK cells control breast cancer and related cancer stem cell hematological spread 299
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 266
Multi-level model for the investigation of oncoantigen- driven vaccination effect 242
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. 234
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 216
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 213
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 212
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 206
Cancer stem cell antigens as targets for new combined anti-cancer therapies 197
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells 197
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 169
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 166
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 163
Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy 156
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 152
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells 145
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy 145
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 141
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 132
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice 129
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 129
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 126
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 121
B7h triggering inhibits the migration of tumor cell lines. 119
Multi-level model for the investigation of oncoantigen-driven vaccination effect 118
Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice 117
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential 117
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 114
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination 107
Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. 104
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 103
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma 103
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 100
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 98
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 95
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 95
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 93
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 86
TYPE 1 INTERFERON RECEPTOR (IFNA-R1). EXPRESSING TH17 LYMPHOCYTES ARE INCREASED DURING MS RELAPSES AND ARE SELECTIVELY INTHBITED BY IFNβ 85
B7h triggering inhibits the migration of tumor cell lines x 84
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta 82
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 82
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 82
T helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β 78
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study 78
B7H triggering inhibits migration of tumor cell lines 77
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes 74
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 73
Flow Cytometry for Beginners: Hints and Tips for Approaching the Very First Single-Cell Technique 72
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 71
T helper 17 Lymphocytes and multiple sclerosis: their increase in active phases of disease and the interferon beta induced inhibition 70
Iron regulates T lymphocyte sensitivity to the IFN-g/STAT1 signaling pathway in vitro and in vivo 69
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta 69
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 68
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta 67
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 66
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 66
IL- 17 and IL-22 producing increased in multiple sclerosis relapses are MBP-specific. A multi-centre longitudinal study 66
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 64
Ready for a new saga? Th17 and not Th1 are selectively increased in active multiple sclerosis and undergo apoptosis with interferon beta 63
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 60
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 60
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? 59
Iron chelation restores human T cells sensitivity to the IFN-g/STAT1 signaling pathway. Jaks and Stats: development to disease 57
JAK2 is overexpressed in human multiple sclerosis Th17 cells andstabilizes cell surface expression of IFN-gammaR2. 56
MBP-Specific Th17 Lymphocytes selectively increase during MS relapses. A multicenter longitudinal Study 54
Interleukin-17 t lymphocyte production correlates with disease activity in Multiple Sclerosis 53
Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. 51
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 49
The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells 48
Ready for a new saga? Th17 and not Th1 are selectivly increate in active multiple sclerosis and undergo apoptosis with interferon beta 47
Tissue memory relies on stem cell priming in distal undamaged areas 46
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy 46
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy 45
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 45
Longitudinal analysis of IL-17 and/or IL-22 producing CD4+ T lymphocytes in relapsing remitting multiple sclerosis 45
A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes 40
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 39
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-gammaR2 35
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment 34
Modulation of STAT1 signaling pathway by Interferons (IFNs) in human T helper (Th)17 lymphocytes 30
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models 28
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 28
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 27
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation 25
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer 22
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 21
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 20
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 19
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine 13
Effect of Mitoquinone on sperm quality of cryopreserved stallion semen 9
Totale 10.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.051
article - articoli 0
book - libri 0
conference - conferenze 5.378
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.028 0 0 0 0 99 228 140 114 151 133 90 73
2020/20211.361 80 69 88 63 98 89 144 79 180 150 133 188
2021/20221.651 100 93 82 155 109 111 110 102 79 183 267 260
2022/20231.918 195 146 53 187 139 458 155 145 179 49 134 78
2023/20241.244 130 153 108 87 114 129 93 88 18 95 113 116
2024/2025952 71 116 144 229 392 0 0 0 0 0 0 0
Totale 10.692